空間ゲノミクス＆トランスクリプトミクス市場：製品、シーケンス方法、用途、エンドユーザー別-2025-2030年世界予測

空間ゲノミクス＆トランスクリプトミクス市場は、2023年に10億5,000万米ドルと評価され、2024年には11億8,000万米ドル、CAGR 12.35%で成長し、2030年には23億8,000万米ドルに達すると予測されています。

空間ゲノミクスとトランスクリプトミクスは、細胞機能と組織構造の理解を再定義する、ライフサイエンスの極めて重要な分野として浮上してきました。イメージング、シークエンシング、計算機によるデータ解析の進歩が融合し、複雑な生物学的現象の解明において空間的文脈が重要な役割を果たす、変革的な学問分野が誕生しました。この新たなパラダイムは、投資の増加に拍車をかけ、研究の視野を広げ、専門家同士の学際的な共同研究を促しています。技術の飛躍的進歩と、人体や疾病メカニズムに対する深い洞察への飽くなき探求に後押しされ、この分野は精密医療の要へと急速に進化しています。現在の状況は、診断アッセイ、創薬、標的治療における革新のための有望な機会を提供し、医療と研究への影響に関する包括的な探求の舞台となっています。この分野が加速するにつれ、研究者や意思決定者は、空間生物学の可能性を生かすために、確立された原則と新たな動向の両方を操らなければならないです。

空間ゲノミクス＆トランスクリプトミクス市場の変革

近年、空間ゲノミクスとトランスクリプトミクスの分野では変革的な変化が起きています。技術の進化は、これまでにない解像度と効率を提供する新しいシーケンスプラットフォームとイメージング技術の開発に拍車をかけた。従来のバルク解析から、シングルセルや空間情報に基づいた研究への移行が進行中であり、この移行は実験デザインとデータ解釈を再定義しつつあります。このような変化は、学際的共同研究による急速な技術革新によって強調されています。計算ツールやデータ解析の進歩は、研究者が組織内の複雑な空間的関係を解読することを可能にし、細胞ネットワーク内の遺伝子発現の空間的オーケストレーションを理解する能力を高めています。このダイナミックな環境は、精密技術が研究を強化するだけでなく、個別化治療や診断の開発を促進する新しい時代の到来を告げています。企業、学会、臨床研究機関は、競争の激しい研究情勢を勝ち抜くために、こうした手法への投資を増やしており、業界関係者はこうした変革的動向に戦略的に適応することが不可欠となっています。

主なセグメンテーションの洞察

空間ゲノミクスとトランスクリプトミクスのセグメンテーションの枠組みを詳細に分析すると、多様な要因によって形成された多面的な市場風景が見えてくる。製品の次元を重要な軸として、市場は消耗品、機器、ソフトウェアに分解されます。消耗品セグメントは、アッセイキットと試薬の文脈で研究され、高精度の分子ツールに対する需要によって力強い成長を示しています。これと並行して、機器セグメントには、空間解析における高分解能の達成に不可欠な最先端の顕微鏡やシーケンスプラットフォームが含まれます。さらに、データ解析プラットフォームや可視化ツールなどのソフトウェアソリューションは、複雑なデータセットの解釈に不可欠な役割を果たしています。in-situシーケンス、マルチプレックスエラーロバスト蛍光in-situハイブリダイゼーション、シーケンシャル蛍光in-situハイブリダイゼーション、Slide-seq、空間トランスクリプトミクスなどのアプローチは、独自の機能と解析の可能性を提供します。アプリケーションを考えるとき、研究の焦点は、腫瘍学プロファイリングや腫瘍微小環境解析における詳細な評価を含むがん研究から、発生生物学、創薬、免疫学、神経学に及ぶ。例えば創薬では、バイオマーカー解析や治療標的同定が重要な研究促進要因として浮上しています。さらに、エンドユーザー別のセグメンテーションでは、生物学部やゲノミクスセンターなどの専門機関に細分化された学術研究機関から、臨床研究機関、製薬会社、バイオテクノロジー会社、基幹施設や非公開研究所を含む研究室まで、さまざまな対象者を明らかにしています。これらのセグメンテーションを総合すると、各セグメンテーションが研究、技術、対象アプリケーションの織り成すエコシステムに貢献している、市場の高度化レベルが明らかになります。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患の罹患率の上昇により、高度な空間ゲノムソリューションの需要が高まっています。
    • 個別化医療における空間ゲノミクスとトランスクリプトミクスの応用の増加
    • 早期発見と診断の重要性が高まり、空間ゲノミクスの革新が促進されている
  • 抑制要因
    • 合理的な時間枠内で高解像度の空間データを取得する際の制限
  • 機会
    • 顕微鏡と画像技術の発達により、ゲノミクス研究における空間分解能と精度が向上しました。
    • ゲノミクス調査への資金増額により空間トランスクリプトミクス研究の発展が促進される
  • 課題
    • 遺伝子および単一細胞シークエンシングにおける償還の不一致と不確実性
• 市場セグメンテーション分析
  • 製品：高いスループットと精度により、研究室でのアッセイキットの使用が増加しています
  • シーケンス法：遺伝子発現の高解像度空間マップによるスライドシーケンスの利用により、重要な洞察が得られます。
  • 応用：創薬と開発の加速における空間ゲノミクスの採用
  • エンドユーザー：臨床試験の精度を高める臨床調査機関を優先
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社会
  • 技術的
  • 法律上
  • 環境

第6章 空間ゲノミクス＆トランスクリプトミクス市場：製品別

• 消耗品
  • アッセイキット
  • 試薬
• 機器
  • 顕微鏡
  • シーケンシングプラットフォーム
• ソフトウェア
  • データ分析プラットフォーム
  • 視覚化ツール

第7章 空間ゲノミクス＆トランスクリプトミクス市場シーケンス法別

• インサイチューシーケンシング
• マルチプレックスエラーロバスト蛍光in situハイブリダイゼーション
• 常用蛍光in situハイブリダイゼーション
• スライドシーケンス
• 空間トランスクリプトミクス

第8章 空間ゲノミクス＆トランスクリプトミクス市場：用途別

• がん調査
  • 腫瘍学プロファイリング
  • 腫瘍微小環境解析
• 発生生物学
• 創薬
  • バイオマーカー分析
  • 治療標的の特定
• 免疫学
• 神経学

第9章 空間ゲノミクス＆トランスクリプトミクス市場：エンドユーザー別

• 学術調査機関
  • 生物学科
  • ゲノミクスセンター
• 臨床調査機関
• 製薬・バイオテクノロジー企業
• 調査室
  • コア施設
  • プライベートラボ

第10章 南北アメリカの空間ゲノミクス＆トランスクリプトミクス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の空間ゲノミクス＆トランスクリプトミクス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの空間ゲノミクス＆トランスクリプトミクス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析, 2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 10x Genomics, Inc.
• Agilent Technologies, Inc.
• Akoya Biosciences, Inc.
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Bio-Techne Corporation
• Bruker Corporation
• Carl Zeiss AG
• Danaher Corporation
• Evident Corporation
• Illumina, Inc.
• Indica Labs, Inc.
• Ionpath, Inc.
• Merck KGaA
• Parse Biosciences
• PerkinElmer, Inc.
• RareCyte, Inc.
• Rebus Biosystems, Inc.
• Resolve Biosciences GmbH.
• S2 Genomics, Inc.
• Seven Bridges Genomics
• Standard BioTools Inc.
• Thermo Fisher Scientific Inc.
• Ultivue, Inc.
• Vizgen Inc.

LIST OF FIGURES

• FIGURE 1. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET MULTI-CURRENCY
• FIGURE 2. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET MULTI-LANGUAGE
• FIGURE 3. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET RESEARCH PROCESS
• FIGURE 4. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, 2023 VS 2030
• FIGURE 5. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET DYNAMICS
• TABLE 7. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY MICROSCOPES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DATA ANALYSIS PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY VISUALIZATION TOOLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY IN SITU SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY MULTIPLEXED ERROR-ROBUST FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENTIAL FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SLIDE-SEQ, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SPATIAL TRANSCRIPTOMICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ONCOLOGY PROFILING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY TUMOR MICROENVIRONMENT ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DEVELOPMENTAL BIOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY BIOMARKER ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY THERAPEUTIC TARGET IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY BIOLOGY DEPARTMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY GENOMICS CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 42. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
• TABLE 43. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 44. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 45. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 46. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CORE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 47. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRIVATE LABS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 48. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 49. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 51. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 52. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 53. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
• TABLE 54. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
• TABLE 56. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 57. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
• TABLE 59. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 60. AMERICAS SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 61. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 63. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 64. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 65. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
• TABLE 66. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
• TABLE 68. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 69. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
• TABLE 71. ARGENTINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 72. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 74. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 75. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 76. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
• TABLE 77. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
• TABLE 79. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 80. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
• TABLE 82. BRAZIL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 83. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 85. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 86. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 87. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
• TABLE 88. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
• TABLE 90. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 91. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
• TABLE 93. CANADA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 94. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 96. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 97. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 98. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
• TABLE 99. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
• TABLE 101. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 102. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 103. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
• TABLE 104. MEXICO SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 105. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 106. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 107. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 108. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 109. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
• TABLE 110. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
• TABLE 112. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 113. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
• TABLE 115. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 116. UNITED STATES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 117. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 118. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 119. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 120. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 121. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
• TABLE 122. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
• TABLE 124. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 125. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
• TABLE 127. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 128. ASIA-PACIFIC SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 129. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 130. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 131. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 132. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 133. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
• TABLE 134. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
• TABLE 136. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 137. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
• TABLE 139. AUSTRALIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 140. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 141. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 142. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 143. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 144. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
• TABLE 145. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
• TABLE 147. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 148. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 149. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
• TABLE 150. CHINA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 151. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 152. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 153. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 154. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 155. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
• TABLE 156. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 157. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
• TABLE 158. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 159. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 160. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
• TABLE 161. INDIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 162. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 163. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 164. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 165. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 166. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
• TABLE 167. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 168. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
• TABLE 169. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 170. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 171. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
• TABLE 172. INDONESIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 173. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 174. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 175. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 176. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 177. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
• TABLE 178. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 179. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
• TABLE 180. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 181. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 182. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
• TABLE 183. JAPAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 184. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 185. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 186. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 187. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 188. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
• TABLE 189. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 190. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
• TABLE 191. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 192. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 193. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
• TABLE 194. MALAYSIA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 195. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 196. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 197. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 198. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 199. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
• TABLE 200. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 201. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
• TABLE 202. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 203. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 204. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
• TABLE 205. PHILIPPINES SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 206. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 207. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 208. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 209. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 210. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
• TABLE 211. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 212. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
• TABLE 213. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 214. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 215. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
• TABLE 216. SINGAPORE SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 217. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 218. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 219. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 220. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 221. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
• TABLE 222. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 223. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
• TABLE 224. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 225. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 226. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
• TABLE 227. SOUTH KOREA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 228. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 229. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 230. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 231. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 232. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
• TABLE 233. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 234. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
• TABLE 235. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 236. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 237. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
• TABLE 238. TAIWAN SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 239. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 240. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 241. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 242. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 243. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
• TABLE 244. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 245. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
• TABLE 246. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 247. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 248. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
• TABLE 249. THAILAND SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 250. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 251. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 252. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 253. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 254. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
• TABLE 255. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 256. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
• TABLE 257. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 258. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 259. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
• TABLE 260. VIETNAM SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 261. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 262. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 263. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 264. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 265. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
• TABLE 266. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 267. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
• TABLE 268. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 269. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 270. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
• TABLE 271. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 272. EUROPE, MIDDLE EAST & AFRICA SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 273. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 274. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 275. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 276. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 277. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
• TABLE 278. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 279. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
• TABLE 280. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 281. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 282. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, 2018-2030 (USD MILLION)
• TABLE 283. DENMARK SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY RESEARCH LABORATORIES, 2018-2030 (USD MILLION)
• TABLE 284. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 285. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
• TABLE 286. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 287. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 288. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY SEQUENCING METHOD, 2018-2030 (USD MILLION)
• TABLE 289. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 290. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY CANCER RESEARCH, 2018-2030 (USD MILLION)
• TABLE 291. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
• TABLE 292. EGYPT SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 293. EGYPT SPATIAL GENOMICS & TRANS

The Spatial Genomics & Transcriptomics Market was valued at USD 1.05 billion in 2023 and is projected to grow to USD 1.18 billion in 2024, with a CAGR of 12.35%, reaching USD 2.38 billion by 2030.

Spatial genomics and transcriptomics have emerged as pivotal areas in life sciences, redefining our understanding of cellular function and tissue architecture. Advances in imaging, sequencing, and computational data analysis have converged to create a transformative discipline, where spatial context plays a critical role in elucidating complex biological phenomena. This new paradigm has fueled increased investments, broadened research horizons, and inspired cross-disciplinary collaboration among experts. Driven by technological breakthroughs and an insatiable quest for deeper insights into the human body and disease mechanisms, this field is rapidly evolving into a cornerstone of precision medicine. The present landscape offers promising opportunities for innovation in diagnostic assays, drug discovery, and targeted therapies, setting the stage for a comprehensive exploration of its impact on medicine and research. As the field accelerates, researchers and decision-makers must navigate both established principles and emerging trends to capitalize on the potential of spatial biology.

Transformative Shifts in the Landscape

Recent years have witnessed transformative shifts within the spatial genomics and transcriptomics arena. Technological evolution has spurred the development of new sequencing platforms and imaging techniques that offer unprecedented resolution and efficiency. An ongoing transition is underway from traditional bulk analyses to single-cell and spatially informed studies, a shift that is redefining experimental design and data interpretation. These changes are underscored by rapid innovation driven by interdisciplinary collaboration. Advances in computational tools and data analytics are now enabling researchers to decode complex spatial relationships in tissues, thus enhancing our ability to understand the spatial orchestration of gene expression within cellular networks. This dynamic environment is heralding a new era where precision techniques not only bolster research but also foster the development of personalized therapies and diagnostics. Enterprises, academicians, and clinical research organizations are increasingly investing in these methodologies to stay ahead in a competitive research landscape, making it imperative for industry stakeholders to adapt strategically to these transformative trends.

Key Segmentation Insights

A detailed analysis of the segmentation framework in spatial genomics and transcriptomics reveals a multi-faceted market landscape shaped by diverse factors. With the product dimension as a crucial axis, the market dissects into consumables, instruments, and software. The consumables segment, studied in the context of assay kits and reagents, demonstrates robust growth driven by demand for high-precision molecular tools. In parallel, the instruments segment encompasses state-of-the-art microscopes and sequencing platforms that are essential for achieving high resolution in spatial analysis. Additionally, software solutions, including data analysis platforms and visualization tools, play an indispensable role in interpreting complex datasets. The evolution of sequencing methodologies further enriches segmentation; approaches such as in situ sequencing, multiplexed error-robust fluorescence in situ hybridization, sequential fluorescence in situ hybridization, Slide-seq, and spatial transcriptomics offer distinct capabilities and analysis potential. When considering applications, research focuses span from cancer research-which includes detailed evaluations in oncology profiling and tumor microenvironment analysis-to developmental biology, drug discovery, immunology, and neurology. In drug discovery, for example, biomarker analysis and therapeutic target identification are emerging as key research drivers. Furthermore, segmentation by end-user highlights audiences ranging from academic research institutions, subdivided into specialized bodies such as biology departments and genomics centers, to clinical research organizations, pharmaceutical and biotechnology companies, and research laboratories that include core facilities along with private labs. Collectively, these segmentation insights underline the level of sophistication present in the market, where each segment contributes to an interwoven ecosystem of research, technology, and targeted application.

Based on Product, market is studied across Consumables, Instruments, and Software. The Consumables is further studied across Assay Kits and Reagents. The Instruments is further studied across Microscopes and Sequencing Platforms. The Software is further studied across Data Analysis Platforms and Visualization Tools.

Based on Sequencing Method, market is studied across In Situ Sequencing, Multiplexed Error-Robust Fluorescence In Situ Hybridization, Sequential Fluorescence In Situ Hybridization, Slide-seq, and Spatial Transcriptomics.

Based on Application, market is studied across Cancer Research, Developmental Biology, Drug Discovery, Immunology, and Neurology. The Cancer Research is further studied across Oncology Profiling and Tumor Microenvironment Analysis. The Drug Discovery is further studied across Biomarker Analysis and Therapeutic Target Identification.

Based on End-User, market is studied across Academic Research Institutions, Clinical Research Organizations, Pharmaceutical & Biotechnology Companies, and Research Laboratories. The Academic Research Institutions is further studied across Biology Departments and Genomics Centers. The Research Laboratories is further studied across Core Facilities and Private Labs.

Key Regional Insights

Geographical trends play a significant role in shaping the spatial genomics and transcriptomics market. In the Americas, a robust network of leading research institutions and a strong focus on precision medicine are driving innovations and adoption. The Europe, Middle East & Africa region sees a confluence of traditional academic excellence and rapidly expanding industrial research, where regulatory frameworks and cross-border collaborations are facilitating advanced studies. Meanwhile, in the Asia-Pacific, dynamic economic growth and substantial investments in biotechnology are fueling rapid market expansion, making it a focal point for transformative research initiatives. These regions collectively provide a heterogeneous landscape of research capabilities and investment opportunities, representing both mature markets and fast-growing territories within the global spatial biology arena. As these regions continue to evolve, strategic geographical insights are essential for aligning research investments with local expertise and global trends.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, Massachusetts, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Insights

Industry leaders are spearheading innovation in spatial genomics and transcriptomics through strategic investments in research and technology development. Prominent companies such as 10x Genomics, Inc. and Agilent Technologies, Inc. are pushing the boundaries by introducing state-of-the-art instruments and consumables that enable unparalleled analytical precision. Akoya Biosciences, Inc. and Becton, Dickinson and Company have become key players by offering comprehensive imaging and diagnostic solutions, while Bio-Rad Laboratories, Inc. and Bio-Techne Corporation continue to enrich the market with high-quality assay kits and reagents. Bruker Corporation and Carl Zeiss AG consolidate their positions by delivering advanced microscopy systems, and Danaher Corporation along with Evident Corporation are renowned for their robust contribution to cutting-edge analytical tools. Illumina, Inc. and Indica Labs, Inc. have set benchmarks in high-throughput sequencing and data management, and innovative solutions from Ionpath, Inc. and Merck KGaA further highlight the competitive spirit in the market. Emerging leaders such as Parse Biosciences, PerkinElmer, Inc., RareCyte, Inc., Rebus Biosystems, Inc., Resolve Biosciences GmbH., S2 Genomics, Inc., Seven Bridges Genomics, Standard BioTools Inc., Thermo Fisher Scientific Inc., Ultivue, Inc., and Vizgen Inc. drive the competitive landscape by constantly exploring new technological frontiers. These companies collectively underscore the market's diverse and competitive ecosystem, where strategic partnerships and continuous innovation are keys to maintaining leadership in this rapidly evolving field.

The report delves into recent significant developments in the Spatial Genomics & Transcriptomics Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., Agilent Technologies, Inc., Akoya Biosciences, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Bruker Corporation, Carl Zeiss AG, Danaher Corporation, Evident Corporation, Illumina, Inc., Indica Labs, Inc., Ionpath, Inc., Merck KGaA, Parse Biosciences, PerkinElmer, Inc., RareCyte, Inc., Rebus Biosystems, Inc., Resolve Biosciences GmbH., S2 Genomics, Inc., Seven Bridges Genomics, Standard BioTools Inc., Thermo Fisher Scientific Inc., Ultivue, Inc., and Vizgen Inc.. Actionable Recommendations for Industry Leaders

Industry leaders should invest in robust cross-disciplinary research collaborations and foster technology partnerships to secure a competitive edge in the spatial genomics and transcriptomics landscape. It is essential to channel resources into state-of-the-art instrumentation and advanced computational analytics, ensuring that new methodologies drive both speed and accuracy in research efforts. Companies must establish agile operational frameworks that allow for rapid adaptation to technological breakthroughs and evolving market paradigms. Auditing current research portfolios and aligning them with emerging trends will enable a seamless transition into areas with high growth potential, particularly in personalized medicine and precision diagnostic platforms. A proactive stance on regulatory compliance and intellectual property management is critical in maintaining market integrity and safeguarding innovations. Furthermore, nurturing talent through strategic training programs and in-house research initiatives will not only drive internal innovation but also solidify partnerships with external academic and clinical institutions. Overall, this multi-pronged approach will position industry stakeholders to successfully navigate the evolving market dynamics and fully capitalize on the transformative potential of spatial genomics and transcriptomics.

Conclusion: A Vision for Future Growth

In conclusion, the landscape of spatial genomics and transcriptomics is poised to unlock unprecedented research opportunities and applications across medicine and biology. The integration of innovative instruments with advanced software solutions and diverse sequencing methodologies is setting new standards in research precision and diagnostic accuracy. Strategic segmentation by product, sequencing method, application, and end-user highlights a complex yet dynamic market structure that caters to various scientific and healthcare needs. Coupled with significant regional and corporate insights, the stage is set for transformative growth driven by relentless innovation and collaborative ingenuity. The future of spatial genomics stands as a testament to the power of next-generation technologies, offering industry leaders a promising horizon to enhance investments and expand their influence in biomedical research.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of chronic diseases drives demand for advanced spatial genomic solutions
    • 5.1.1.2. Increasing applications of spatial genomics and transcriptomics in personalized medicine
    • 5.1.1.3. Growing emphasis on early detection and diagnosis fueling innovations in spatial genomics
  • 5.1.2. Restraints
    • 5.1.2.1. Limitations in capturing high-resolution spatial data within reasonable timeframes
  • 5.1.3. Opportunities
    • 5.1.3.1. Developments in microscopy and imaging techniques enhancing spatial resolution and accuracy in genomics studies
    • 5.1.3.2. Increased funding for genomics research boosting developments in spatial transcriptomics studies
  • 5.1.4. Challenges
    • 5.1.4.1. Reimbursement inconsistency and uncertainty in gene & single-cell sequencing
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Increasing usage for assay kits in laboratories due to their high throughput and accuracy
  • 5.2.2. Sequencing Method: Utilization of slide-seq due to high-resolution spatial maps of gene expression, providing critical insights
  • 5.2.3. Application: Adoption of spatial genomics in accelerating drug discovery and development
  • 5.2.4. End-User: Preference for clinical research organizations enhancing precision in clinical trials
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Spatial Genomics & Transcriptomics Market, by Product

• 6.1. Introduction
• 6.2. Consumables
  • 6.2.1. Assay Kits
  • 6.2.2. Reagents
• 6.3. Instruments
  • 6.3.1. Microscopes
  • 6.3.2. Sequencing Platforms
• 6.4. Software
  • 6.4.1. Data Analysis Platforms
  • 6.4.2. Visualization Tools

7. Spatial Genomics & Transcriptomics Market, by Sequencing Method

• 7.1. Introduction
• 7.2. In Situ Sequencing
• 7.3. Multiplexed Error-Robust Fluorescence In Situ Hybridization
• 7.4. Sequential Fluorescence In Situ Hybridization
• 7.5. Slide-seq
• 7.6. Spatial Transcriptomics

8. Spatial Genomics & Transcriptomics Market, by Application

• 8.1. Introduction
• 8.2. Cancer Research
  • 8.2.1. Oncology Profiling
  • 8.2.2. Tumor Microenvironment Analysis
• 8.3. Developmental Biology
• 8.4. Drug Discovery
  • 8.4.1. Biomarker Analysis
  • 8.4.2. Therapeutic Target Identification
• 8.5. Immunology
• 8.6. Neurology

9. Spatial Genomics & Transcriptomics Market, by End-User

• 9.1. Introduction
• 9.2. Academic Research Institutions
  • 9.2.1. Biology Departments
  • 9.2.2. Genomics Centers
• 9.3. Clinical Research Organizations
• 9.4. Pharmaceutical & Biotechnology Companies
• 9.5. Research Laboratories
  • 9.5.1. Core Facilities
  • 9.5.2. Private Labs

10. Americas Spatial Genomics & Transcriptomics Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Spatial Genomics & Transcriptomics Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Spatial Genomics & Transcriptomics Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Vizgen launch CSP program to broaden single-cell spatial genomics access
  • 13.3.2. Complete Genomics announces exclusive agreement with STOmics spatial transcriptomics and launches spatial Xcellerator grant
  • 13.3.3. Vizgen and Ultivue announce merger to propel innovation in spatial genomics and proteomics
  • 13.3.4. Lunaphore partners with Discovery Life Sciences to bring innovative spatial biology solutions to clinical research
  • 13.3.5. Deerfield proposes acquisition of Singular Genomics to enhance strategic growth in genomics and multiomics technologies
  • 13.3.6. Moleculent secures USD 26 million in series A funding to propel innovations in spatial genomics and transcriptomics
  • 13.3.7. Bruker acquires NanoString spatial biology business to enhance genomic solutions
  • 13.3.8. 10x Genomics launch Visium HD for advanced single cell-scale spatial transcriptome analysis
  • 13.3.9. DNAnexus and Curio Bioscience collaborate to enhance data analysis for spatial transcriptomics projects
  • 13.3.10. Singular Genomics launches G4X spatial sequencer to enhancing multiomic analysis efficiency
• 13.4. Strategy Analysis & Recommendation
  • 13.4.1. Becton, Dickinson and Company
  • 13.4.2. Agilent Technologies, Inc.
  • 13.4.3. Bruker Corporation
  • 13.4.4. 10x Genomics, Inc.

Companies Mentioned

• 1. 10x Genomics, Inc.
• 2. Agilent Technologies, Inc.
• 3. Akoya Biosciences, Inc.
• 4. Becton, Dickinson and Company
• 5. Bio-Rad Laboratories, Inc.
• 6. Bio-Techne Corporation
• 7. Bruker Corporation
• 8. Carl Zeiss AG
• 9. Danaher Corporation
• 10. Evident Corporation
• 11. Illumina, Inc.
• 12. Indica Labs, Inc.
• 13. Ionpath, Inc.
• 14. Merck KGaA
• 15. Parse Biosciences
• 16. PerkinElmer, Inc.
• 17. RareCyte, Inc.
• 18. Rebus Biosystems, Inc.
• 19. Resolve Biosciences GmbH.
• 20. S2 Genomics, Inc.
• 21. Seven Bridges Genomics
• 22. Standard BioTools Inc.
• 23. Thermo Fisher Scientific Inc.
• 24. Ultivue, Inc.
• 25. Vizgen Inc.